BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Adachi S, Yasuda I, Nakashima M, Yamauchi T, Yoshioka T, Okano Y, Moriwaki H, Kozawa O. Rho-kinase inhibitor upregulates migration by altering focal adhesion formation via the Akt pathway in colon cancer cells. Eur J Pharmacol 2011;650:145-50. [PMID: 20959118 DOI: 10.1016/j.ejphar.2010.10.014] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen J, Ma M, Shen N, Xi JJ, Tian W. Integration of cancer gene co-expression network and metabolic network to uncover potential cancer drug targets. J Proteome Res 2013;12:2354-64. [PMID: 23590569 DOI: 10.1021/pr400162t] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
2 Kawaguchi J, Adachi S, Yasuda I, Yamauchi T, Yoshioka T, Itani M, Kozawa O, Moriwaki H. UVC irradiation suppresses platelet-derived growth factor-BB-induced migration in human pancreatic cancer cells. Oncol Rep 2012;27:935-9. [PMID: 22200892 DOI: 10.3892/or.2011.1612] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
3 de Sousa GR, Vieira GM, das Chagas PF, Pezuk JA, Brassesco MS. Should we keep rocking? Portraits from targeting Rho kinases in cancer. Pharmacol Res 2020;160:105093. [PMID: 32726671 DOI: 10.1016/j.phrs.2020.105093] [Reference Citation Analysis]
4 Santhana Kumar K, Neve A, Guerreiro Stucklin AS, Kuzan-Fischer CM, Rushing EJ, Taylor MD, Tripolitsioti D, Behrmann L, Kirschenbaum D, Grotzer MA, Baumgartner M. TGF-β Determines the Pro-migratory Potential of bFGF Signaling in Medulloblastoma. Cell Rep 2018;23:3798-3812.e8. [PMID: 29949765 DOI: 10.1016/j.celrep.2018.05.083] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
5 Poisson L, Lopez-Charcas O, Chadet S, Bon E, Lemoine R, Brisson L, Ouaissi M, Baron C, Besson P, Roger S, Moussata D. Rock inhibition promotes NaV1.5 sodium channel-dependent SW620 colon cancer cell invasiveness. Sci Rep 2020;10:13350. [PMID: 32770034 DOI: 10.1038/s41598-020-70378-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Srinivasan S, Das S, Surve V, Srivastava A, Kumar S, Jain N, Sawant A, Nayak C, Purwar R. Blockade of ROCK inhibits migration of human primary keratinocytes and malignant epithelial skin cells by regulating actomyosin contractility. Sci Rep 2019;9:19930. [PMID: 31882703 DOI: 10.1038/s41598-019-56447-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Biber G, Ben-Shmuel A, Sabag B, Barda-Saad M. Actin regulators in cancer progression and metastases: From structure and function to cytoskeletal dynamics. Int Rev Cell Mol Biol 2020;356:131-96. [PMID: 33066873 DOI: 10.1016/bs.ircmb.2020.05.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Clayton NS, Ridley AJ. Targeting Rho GTPase Signaling Networks in Cancer. Front Cell Dev Biol 2020;8:222. [PMID: 32309283 DOI: 10.3389/fcell.2020.00222] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 31.0] [Reference Citation Analysis]
9 Umesalma S, Sudhandiran G. Ellagic acid prevents rat colon carcinogenesis induced by 1, 2 dimethyl hydrazine through inhibition of AKT-phosphoinositide-3 kinase pathway. European Journal of Pharmacology 2011;660:249-58. [DOI: 10.1016/j.ejphar.2011.03.036] [Cited by in Crossref: 71] [Cited by in F6Publishing: 61] [Article Influence: 7.1] [Reference Citation Analysis]
10 Ducarouge B, Pelissier-Rota M, Lainé M, Cristina N, Vachez Y, Scoazec JY, Bonaz B, Jacquier-Sarlin M. CRF2 signaling is a novel regulator of cellular adhesion and migration in colorectal cancer cells. PLoS One 2013;8:e79335. [PMID: 24260200 DOI: 10.1371/journal.pone.0079335] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
11 Cascione M, De Matteis V, Toma CC, Pellegrino P, Leporatti S, Rinaldi R. Morphomechanical and structural changes induced by ROCK inhibitor in breast cancer cells. Exp Cell Res 2017;360:303-9. [PMID: 28935466 DOI: 10.1016/j.yexcr.2017.09.020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
12 Nakashima M, Adachi S, Yasuda I, Yamauchi T, Kawaguchi J, Hanamatsu T, Yoshioka T, Okano Y, Hirose Y, Kozawa O, Moriwaki H. Inhibition of Rho-associated coiled-coil containing protein kinase enhances the activation of epidermal growth factor receptor in pancreatic cancer cells. Mol Cancer 2011;10:79. [PMID: 21722395 DOI: 10.1186/1476-4598-10-79] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
13 Zhu Q, Wu Y, Yang M, Wang Z, Zhang H, Jiang X, Chen M, Jin T, Wang T. IRX5 promotes colorectal cancer metastasis by negatively regulating the core components of the RHOA pathway. Mol Carcinog 2019;58:2065-76. [PMID: 31432570 DOI: 10.1002/mc.23098] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
14 Yang J, Wang WG, Zhang KQ. LINC00452 promotes ovarian carcinogenesis through increasing ROCK1 by sponging miR-501-3p and suppressing ubiquitin-mediated degradation. Aging (Albany NY) 2020;12:21129-46. [PMID: 33168781 DOI: 10.18632/aging.103758] [Reference Citation Analysis]
15 Sun S, Song Z, Cotler SJ, Cho M. Biomechanics and functionality of hepatocytes in liver cirrhosis. J Biomech 2014;47:2205-10. [PMID: 24262849 DOI: 10.1016/j.jbiomech.2013.10.050] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
16 Chang F, Zhang Y, Mi J, Zhou Q, Bai F, Xu X, Fisher DE, Sun Q, Wu X. ROCK inhibitor enhances the growth and migration of BRAF-mutant skin melanoma cells. Cancer Sci 2018;109:3428-37. [PMID: 30168234 DOI: 10.1111/cas.13786] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
17 Wei L, Surma M, Shi S, Lambert-Cheatham N, Shi J. Novel Insights into the Roles of Rho Kinase in Cancer. Arch Immunol Ther Exp (Warsz) 2016;64:259-78. [PMID: 26725045 DOI: 10.1007/s00005-015-0382-6] [Cited by in Crossref: 104] [Cited by in F6Publishing: 95] [Article Influence: 20.8] [Reference Citation Analysis]
18 Kargl J, Andersen L, Hasenöhrl C, Feuersinger D, Stančić A, Fauland A, Magnes C, El-Heliebi A, Lax S, Uranitsch S, Haybaeck J, Heinemann A, Schicho R. GPR55 promotes migration and adhesion of colon cancer cells indicating a role in metastasis. Br J Pharmacol 2016;173:142-54. [PMID: 26436760 DOI: 10.1111/bph.13345] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 8.8] [Reference Citation Analysis]
19 Minelli R, Serpe L, Pettazzoni P, Minero V, Barrera G, Gigliotti C, Mesturini R, Rosa AC, Gasco P, Vivenza N. Cholesteryl butyrate solid lipid nanoparticles inhibit the adhesion and migration of colon cancer cells. Br J Pharmacol. 2012;166:587-601. [PMID: 22049973 DOI: 10.1111/j.1476-5381.2011.01768.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
20 Sari I, Berberoglu B, Ozkara E, Oztuzcu S, Camci C, Demiryurek AT. Role of Rho-Kinase Gene Polymorphisms and Protein Expressions in Colorectal Cancer Development. Pathobiology 2013;80:138-45. [DOI: 10.1159/000341395] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
21 Ruggiero C, Lalli E. Targeting the cytoskeleton against metastatic dissemination. Cancer Metastasis Rev 2021;40:89-140. [PMID: 33471283 DOI: 10.1007/s10555-020-09936-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
22 Wilhelm I, Fazakas C, Molnár J, Haskó J, Végh AG, Cervenak L, Nagyőszi P, Nyúl-Tóth A, Farkas AE, Bauer H, Guillemin GJ, Bauer HC, Váró G, Krizbai IA. Role of Rho/ROCK signaling in the interaction of melanoma cells with the blood-brain barrier. Pigment Cell Melanoma Res 2014;27:113-23. [PMID: 24148763 DOI: 10.1111/pcmr.12169] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]